Predicta Med
AI-powered platform for early detection and treatment selection of autoimmune diseases.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does Predicta Med do?
Predicta Med provides a holistic AI platform for autoimmune specialty care optimization, combining clinical algorithms, EMR integration, and specialty-specific intelligence. Their solutions, including PredictAI for early detection and PredictaChart for smart patient chart summaries, empower specialty care providers to streamline decision-making, personalize care, and improve patient outcomes. The platform also supports primary care providers in managing complex autoimmune cases.
How much funding has Predicta Med raised?
Predicta Med has raised a total of $1M in funding. The most recent round on record is Strategic.
Where is Predicta Med headquartered?
Predicta Med is headquartered in Tel Aviv, Israel.
When was Predicta Med founded?
Predicta Med was founded in 2019.
What industry does Predicta Med operate in?
Predicta Med operates in Healthcare, Disease, Detection, Autoimmune, HealthTech, MedTech.
How many employees does Predicta Med have?
Predicta Med has approximately 21 people on record.